Cargando…
miR-208b-5p inhibits invasion of non-small cell lung cancer through the STAT3 pathway by targeting interleukin-9
Previous studies reported a dysregulation of micro (mi)R-208b-5p expression level in various types of human cancer; however, the role of miR-208-5p in non-small cell lung cancer (NSCLC) remains unclear. Therefore, the present study aimed to determine whether miR-208b-5p could regulate NSCLC progress...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285925/ https://www.ncbi.nlm.nih.gov/pubmed/32565956 http://dx.doi.org/10.3892/ol.2020.11570 |
_version_ | 1783544787917340672 |
---|---|
author | Ma, Jun Tong, Hong-Feng Lin, Jie-Huan Chen, Fu-Nan Wu, Can-Xing Cao, Cheng-Zhang Wu, Jian Hu, Shu-Qiao |
author_facet | Ma, Jun Tong, Hong-Feng Lin, Jie-Huan Chen, Fu-Nan Wu, Can-Xing Cao, Cheng-Zhang Wu, Jian Hu, Shu-Qiao |
author_sort | Ma, Jun |
collection | PubMed |
description | Previous studies reported a dysregulation of micro (mi)R-208b-5p expression level in various types of human cancer; however, the role of miR-208-5p in non-small cell lung cancer (NSCLC) remains unclear. Therefore, the present study aimed to determine whether miR-208b-5p could regulate NSCLC progression. A total of 62 pairs of primary tumor and adjacent normal tissues were collected from patients with NSCLC. miR-208b-5p expression level was determined by reverse transcription-quantitative polymerase chain reaction. Furthermore, miR-208b-5p mimics was transfected into NSCLC A549 and H1299 cells in order to upregulate miR-208b-5p expression. Dual-luciferase reporter assay was utilized to investigate the associations between miR-208b-5p and IL9 mRNA. The results demonstrated that miR-208b-5p expression decreased in NSCLC tissues and cell lines. Furthermore, miR-208b-5p overexpression inhibited A549 and H1299 cell proliferation and invasiveness. miR-208b-5p was demonstrated to bind directly to the 3′ untranslated region of interleukin-9 (IL-9) and therefore decreased its expression. In the NSCLC-derived cell lines, miR-208b-5p inactivated IL-9/signal transducer and activator of transcription 3 (STAT3) signaling pathway. Furthermore, enhanced IL-9 level decreased the miR-208b-5p-mediated suppression of epithelial-mesenchymal transition in NSCLC cells by inactivating the STAT3 signaling pathway. In conclusion, the findings from this study demonstrated that miR-208b-5p inhibited migration and invasion of NSCLC cells. The anti-tumor activity of miR-208b-5p may be mediated by IL-9 and STAT-3 pathway. |
format | Online Article Text |
id | pubmed-7285925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-72859252020-06-18 miR-208b-5p inhibits invasion of non-small cell lung cancer through the STAT3 pathway by targeting interleukin-9 Ma, Jun Tong, Hong-Feng Lin, Jie-Huan Chen, Fu-Nan Wu, Can-Xing Cao, Cheng-Zhang Wu, Jian Hu, Shu-Qiao Oncol Lett Articles Previous studies reported a dysregulation of micro (mi)R-208b-5p expression level in various types of human cancer; however, the role of miR-208-5p in non-small cell lung cancer (NSCLC) remains unclear. Therefore, the present study aimed to determine whether miR-208b-5p could regulate NSCLC progression. A total of 62 pairs of primary tumor and adjacent normal tissues were collected from patients with NSCLC. miR-208b-5p expression level was determined by reverse transcription-quantitative polymerase chain reaction. Furthermore, miR-208b-5p mimics was transfected into NSCLC A549 and H1299 cells in order to upregulate miR-208b-5p expression. Dual-luciferase reporter assay was utilized to investigate the associations between miR-208b-5p and IL9 mRNA. The results demonstrated that miR-208b-5p expression decreased in NSCLC tissues and cell lines. Furthermore, miR-208b-5p overexpression inhibited A549 and H1299 cell proliferation and invasiveness. miR-208b-5p was demonstrated to bind directly to the 3′ untranslated region of interleukin-9 (IL-9) and therefore decreased its expression. In the NSCLC-derived cell lines, miR-208b-5p inactivated IL-9/signal transducer and activator of transcription 3 (STAT3) signaling pathway. Furthermore, enhanced IL-9 level decreased the miR-208b-5p-mediated suppression of epithelial-mesenchymal transition in NSCLC cells by inactivating the STAT3 signaling pathway. In conclusion, the findings from this study demonstrated that miR-208b-5p inhibited migration and invasion of NSCLC cells. The anti-tumor activity of miR-208b-5p may be mediated by IL-9 and STAT-3 pathway. D.A. Spandidos 2020-07 2020-04-23 /pmc/articles/PMC7285925/ /pubmed/32565956 http://dx.doi.org/10.3892/ol.2020.11570 Text en Copyright: © Ma et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Ma, Jun Tong, Hong-Feng Lin, Jie-Huan Chen, Fu-Nan Wu, Can-Xing Cao, Cheng-Zhang Wu, Jian Hu, Shu-Qiao miR-208b-5p inhibits invasion of non-small cell lung cancer through the STAT3 pathway by targeting interleukin-9 |
title | miR-208b-5p inhibits invasion of non-small cell lung cancer through the STAT3 pathway by targeting interleukin-9 |
title_full | miR-208b-5p inhibits invasion of non-small cell lung cancer through the STAT3 pathway by targeting interleukin-9 |
title_fullStr | miR-208b-5p inhibits invasion of non-small cell lung cancer through the STAT3 pathway by targeting interleukin-9 |
title_full_unstemmed | miR-208b-5p inhibits invasion of non-small cell lung cancer through the STAT3 pathway by targeting interleukin-9 |
title_short | miR-208b-5p inhibits invasion of non-small cell lung cancer through the STAT3 pathway by targeting interleukin-9 |
title_sort | mir-208b-5p inhibits invasion of non-small cell lung cancer through the stat3 pathway by targeting interleukin-9 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285925/ https://www.ncbi.nlm.nih.gov/pubmed/32565956 http://dx.doi.org/10.3892/ol.2020.11570 |
work_keys_str_mv | AT majun mir208b5pinhibitsinvasionofnonsmallcelllungcancerthroughthestat3pathwaybytargetinginterleukin9 AT tonghongfeng mir208b5pinhibitsinvasionofnonsmallcelllungcancerthroughthestat3pathwaybytargetinginterleukin9 AT linjiehuan mir208b5pinhibitsinvasionofnonsmallcelllungcancerthroughthestat3pathwaybytargetinginterleukin9 AT chenfunan mir208b5pinhibitsinvasionofnonsmallcelllungcancerthroughthestat3pathwaybytargetinginterleukin9 AT wucanxing mir208b5pinhibitsinvasionofnonsmallcelllungcancerthroughthestat3pathwaybytargetinginterleukin9 AT caochengzhang mir208b5pinhibitsinvasionofnonsmallcelllungcancerthroughthestat3pathwaybytargetinginterleukin9 AT wujian mir208b5pinhibitsinvasionofnonsmallcelllungcancerthroughthestat3pathwaybytargetinginterleukin9 AT hushuqiao mir208b5pinhibitsinvasionofnonsmallcelllungcancerthroughthestat3pathwaybytargetinginterleukin9 |